{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:45:37Z","timestamp":1790318737913,"version":"4.1.0"},"reference-count":363,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2014\/50928-2"],"award-info":[{"award-number":["#2014\/50928-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Conselho Nacional de Pesquisa","award":["#465687\/2014-8"],"award-info":[{"award-number":["#465687\/2014-8"]}]},{"name":"European Commission under Horizon 2020\u2019s Marie Sk\u0142odowska-Curie Actions COFUND scheme","award":["712754"],"award-info":[{"award-number":["712754"]}]},{"name":"Spanish Ministry of Science and Competitiveness","award":["SEV-2014-0425 (2015-2019)"],"award-info":[{"award-number":["SEV-2014-0425 (2015-2019)"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.addr.2020.02.005","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T11:25:38Z","timestamp":1582802738000},"page":"109-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Nanotechnology approaches in the current therapy of skin cancer"],"prefix":"10.1016","volume":"153","author":[{"given":"Livia Neves","family":"Borgheti-Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Santos Rosa","family":"Viegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Vitoria Pupo","family":"Silvestrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Luis","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola Garcia","family":"Pra\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Kravicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vit\u00f3ria Lopes Badra","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2020.02.005_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature21056","article-title":"Dermatologist-level classification of skin cancer with deep neural networks","volume":"542","author":"Esteva","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.005_bb0010","series-title":"American Cancer Society. Cancer Facts & Figures 2019","author":"Facts","year":"2019"},{"key":"10.1016\/j.addr.2020.02.005_bb0015","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.addr.2020.02.005_bb0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pmedr.2018.04.011","article-title":"Psychosocial consequences of skin cancer screening","volume":"10","author":"Risica","year":"2018","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.addr.2020.02.005_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/15459624.2018.1447118","article-title":"The economic burden of occupational non-melanoma skin cancer due to solar radiation","volume":"15","author":"Mofidi","year":"2018","journal-title":"J. Occup. Environ. Hyg."},{"key":"10.1016\/j.addr.2020.02.005_bb0030","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2147\/IJN.S129976","article-title":"Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the underexpression of glucosamine 6-phosphate N-acetyltransferase 1 (GNPNAT1\/GNA1)","volume":"12","author":"Zhao","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2020.02.005_bb0035","article-title":"An overview of cancer nanomedicine on the market and in clinical trials","volume":"3","author":"Wang","year":"2015","journal-title":"J. Coast. Life Med."},{"key":"10.1016\/j.addr.2020.02.005_bb0040","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1158\/1078-0432.CCR-04-2291","article-title":"Comparative preclinical and clinical pharmacokinetics of a Cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in cremophor (Taxol)","volume":"11","author":"Sparreboom","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2020.02.005_bb0045","author":"Clinical Trials"},{"key":"10.1016\/j.addr.2020.02.005_bb0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.addr.2020.02.005_bb0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.addr.2017.09.016","article-title":"Targeted drug delivery to melanoma","volume":"127","author":"Liu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0060","article-title":"The world of melanoma: epidemiologic, genetic, and anatomic differences of melanoma across the globe","volume":"20","author":"Krattinger","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.addr.2020.02.005_bb0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/pcmr.12459","article-title":"The genomic landscape of cutaneous melanoma","volume":"29","author":"Zhang","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.addr.2020.02.005_bb0070","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/exd.13309","article-title":"Overcoming cell death resistance in skin cancer therapy: novel translational perspectives","volume":"26","author":"Feoktistova","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2020.02.005_bb0075","first-page":"461","article-title":"Elective lymph node dissection in patients with melanoma","volume":"137","author":"Lens","year":"2003","journal-title":"Arch. Surg."},{"key":"10.1016\/j.addr.2020.02.005_bb0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2011.06.029","article-title":"Grenz ray treatment of lentigo maligna and early lentigo maligna melanoma","volume":"67","author":"Hedblad","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.02.005_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11060-013-1127-1","article-title":"Vemurafenib and radiation therapy in melanoma brain metastases","volume":"113","author":"Narayana","year":"2013","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.addr.2020.02.005_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/biomedicines6010006","article-title":"Non melanoma skin cancer pathogenesis overview","volume":"6","author":"Didona","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.addr.2020.02.005_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2018.03.060","article-title":"Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations","volume":"80","author":"Cameron","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.02.005_bb0100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/DSS.0000000000000296","article-title":"Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods","volume":"41","author":"Kauvar","year":"2015","journal-title":"Dermatologic Surg."},{"key":"10.1016\/j.addr.2020.02.005_bb0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/ijd.12553","article-title":"Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends","volume":"54","author":"Kallini","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.addr.2020.02.005_bb0110","first-page":"1","article-title":"A review of cutaneous squamous cell carcinoma epidemiology, diagnosis, and management","author":"Kabir","year":"2018","journal-title":"Int. J. Cancer Manag."},{"key":"10.1016\/j.addr.2020.02.005_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjd.15324","article-title":"Cutaneous squamous cell carcinoma: an epidemiological review","volume":"177","author":"Green","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2020.02.005_bb0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13555-016-0165-y","article-title":"Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"10.1016\/j.addr.2020.02.005_bb0125","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1517\/14656566.2010.481284","article-title":"Treating skin cancer with topical cream","volume":"11","author":"Micali","year":"2010","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.addr.2020.02.005_bb0130","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/j.1524-4725.2011.02088.x","article-title":"Treatment of squamous cell carcinoma in situ: a review","volume":"37","author":"Shimizu","year":"2011","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2020.02.005_bb0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/intimm\/dxv013","article-title":"Dissecting the formation, structure and barrier function of the stratum corneum","volume":"27","author":"Matsui","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.addr.2020.02.005_bb0140","series-title":"Rook\u2019s Textb. Dermatology","first-page":"1","article-title":"Anatomy and organization of human skin","author":"McGrath","year":"2010"},{"key":"10.1016\/j.addr.2020.02.005_bb0145","doi-asserted-by":"crossref","DOI":"10.4155\/tde.15.20","article-title":"Advances in the bioanalytical study of drug delivery across the skin","volume":"6","author":"Depieri","year":"2015","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2020.02.005_bb0150","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.2174\/1381612811319350011","article-title":"Penetration of nanoparticles into human skin","volume":"19","author":"Liang","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2020.02.005_bb0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.vibspec.2018.11.009","article-title":"Discrimination of non-melanoma skin cancer and keratosis from normal skin tissue in vivo and ex vivo by Raman spectroscopy","volume":"100","author":"Ferreira Lima","year":"2019","journal-title":"Vib. Spectrosc."},{"key":"10.1016\/j.addr.2020.02.005_bb0160","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41416-018-0257-9","article-title":"Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy","volume":"119","author":"Santos","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2020.02.005_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2020.02.005_bb0170","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1080\/21691401.2018.1498349","article-title":"Pharmacotherapeutic approaches for transportation of anticancer agents via skin","volume":"46","author":"Shende","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.addr.2020.02.005_bb0175","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/21691401.2018.1430695","article-title":"Passive delivery of protein drugs through transdermal route","volume":"46","author":"Chaulagain","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.addr.2020.02.005_bb0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0185","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2020.02.005_bb0190","series-title":"Gastroenterol. Hepatol. From Bed to Bench","first-page":"25","article-title":"Enhanced Permeability and Retention (EPR) effect for anticancer nanomedicine drug targeting","author":"Greish","year":"2010"},{"key":"10.1016\/j.addr.2020.02.005_bb0195","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanormedicine to solit tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.addr.2020.02.005_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine","author":"Donahue","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrm.2017.132","article-title":"Mechanisms of clathrin-mediated endocytosis","volume":"19","author":"Kaksonen","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2020.02.005_bb0210","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/nn9012274","article-title":"Size and dynamics of caveolae studied using nanoparticles in living endothelial cells","volume":"3","author":"Wang","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.02.005_bb0215","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.7150\/thno.23459","article-title":"Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications","volume":"8","author":"Wu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2020.02.005_bb0220","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s11095-013-0971-1","article-title":"Delivery systems and local administration routes for therapeutic siRNA","volume":"30","author":"Vicentini","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.02.005_bb0225","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jamadermatol.2018.1748","article-title":"Combined systemic and intratumoral administration of human papillomavirus vaccine to treat multiple cutaneous basaloid squamous cell carcinomas","volume":"154","author":"Nichols","year":"2018","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.addr.2020.02.005_bb0230","first-page":"E8698","article-title":"Adjuvant effect of the novel TLR1\/TLR2 agonist diprovocim synergizes with anti\u2013PD-L1 to eliminate melanoma in mice","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.colsurfb.2018.03.009","article-title":"Intratumoral administration of carboplatin bearing poly (\u03b5-caprolactone) nanoparticles amalgamated with in situ gel tendered augmented drug delivery, cytotoxicity, and apoptosis in melanoma tumor","volume":"166","author":"Bragta","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb0240","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1021\/acs.molpharmaceut.6b01141","article-title":"In situ gelling liquid crystalline system as local siRNA delivery system","volume":"14","author":"Borgheti-Cardoso","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bb0245","first-page":"1","article-title":"Diverse targeted approaches to battle multidrug resistance in cancer","volume":"25","author":"Shankaraiah","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2020.02.005_bb0250","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.addr.2013.09.017","article-title":"Nanotechnology approaches for personalized treatment of multidrug resistant cancers","volume":"65","author":"Minko","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/635745","article-title":"Overcoming multidrug resistance in cancer stem cells","volume":"2015","author":"Moitra","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.addr.2020.02.005_bb0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drup.2017.05.002","article-title":"Targeted nanomedicine for cancer therapeutics: towards precision medicine overcoming drug resistance","volume":"31","author":"Bar-Zeev","year":"2017","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.addr.2020.02.005_bb0265","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/17425247.2015.960920","article-title":"Overcoming multidrug resistance with nanomedicines","volume":"12","author":"Ganoth","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2020.02.005_bb0270","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2217\/nnm-2017-0145","article-title":"New strategies in melanoma therapy: can nanoparticles overcome chemoresistance?","volume":"12","author":"Badea","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2020.02.005_bb0275","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","article-title":"The challenge of drug resistance in cancer treatment: a current overview","volume":"35","author":"Nikolaou","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.addr.2020.02.005_bb0280","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/07388551.2015.1015957","article-title":"Molecular mechanisms of drug resistance and its reversal in cancer","volume":"36","author":"Kartal-Yandim","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.addr.2020.02.005_bb0285","first-page":"19","article-title":"Chemotherapy resistance mechanisms in advanced skin cancer","volume":"11","author":"Kalal","year":"2017","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0290","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2016.06.003","article-title":"A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery","volume":"235","author":"Bao","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0295","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3892\/or.2016.5342","article-title":"Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells","volume":"37","author":"Jiang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.addr.2020.02.005_bb0300","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1016\/j.biomaterials.2012.05.035","article-title":"TAT-modified nanosilver for combating multidrug-resistant cancer","volume":"33","author":"Liu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb0305","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1039\/C8TB01810C","article-title":"Overcoming drug resistance with functional mesoporous titanium dioxide nanoparticles combining targeting, drug delivery and photodynamic therapy","volume":"6","author":"Guo","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2020.02.005_bb0310","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/smll.200900621","article-title":"Co-delivery of Doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells","volume":"5","author":"Chen","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.addr.2020.02.005_bb0315","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.2174\/1381612821666150428124053","article-title":"Overcoming the skin permeation barrier: challenges and opportunities","volume":"21","author":"Vitorino","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2020.02.005_bb0320","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2015.10.049","article-title":"Nanoparticles and nanofibers for topical drug delivery","volume":"240","author":"Goyal","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0325","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2016.06.016","article-title":"Nanoparticle design considerations for molecular imaging of apoptosis: diagnostic, prognostic, and therapeutic value","volume":"113","author":"Savla","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0330","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1208\/s12248-016-9961-7","article-title":"Nanomedicines: from bench to bedside and beyond","volume":"18","author":"Havel","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2020.02.005_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: principles, properties, and regulatory issues","volume":"6","author":"Soares","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2020.02.005_bb0340","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2020.02.005_bb0345","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2174\/0929867324666171009120154","article-title":"Recent advances and perspectives in liposomes for cutaneous drug delivery","volume":"25","author":"Carita","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2020.02.005_bb0350","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3389\/fphar.2015.00219","article-title":"Lipid-based nano-delivery systems for skin delivery of drugs and bioactives","volume":"6","author":"Hua","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2020.02.005_bb0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4161\/derm.1.4.9501","article-title":"Nanoparticles and their interactions with the dermal barrier","volume":"1","author":"Schneider","year":"2009","journal-title":"Dermatoendocrinol."},{"key":"10.1016\/j.addr.2020.02.005_bb0360","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S86186","article-title":"Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes","volume":"10","author":"Ascenso","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2020.02.005_bb0365","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle\u2013liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0370","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s11095-010-0360-y","article-title":"Intratumoral drug delivery with nanoparticulate carriers","volume":"28","author":"Holback","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.02.005_bb0375","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.addr.2012.04.010","article-title":"Nanoparticles in drug delivery: past, present and future","volume":"65","author":"Couvreur","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0380","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2018.06.009","article-title":"Practical guidelines for the characterization and quality control of pure drug nanoparticles and nano-cocrystals in the pharmaceutical industry","volume":"131","author":"Peltonen","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0385","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.yrtph.2015.05.005","article-title":"Nanoparticles skin absorption: new aspects for a safety profile evaluation","volume":"72","author":"Larese Filon","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.addr.2020.02.005_bb0390","first-page":"86","article-title":"Development of PLGA micro- and nanorods with high capacity of surface ligand conjugation for enhanced targeted delivery","volume":"14","author":"Cao","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0395","doi-asserted-by":"crossref","first-page":"17075","DOI":"10.1038\/micronano.2017.75","article-title":"Nanoimprint lithography steppers for volume fabrication of leading-edge semiconductor integrated circuits","volume":"3","author":"Sreenivasan","year":"2017","journal-title":"Microsyst. Nanoeng."},{"key":"10.1016\/j.addr.2020.02.005_bb0400","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1517\/17425247.2015.963055","article-title":"Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications","volume":"12","author":"Mathaes","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2020.02.005_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep16908","article-title":"Shape-dependent skin penetration of silver nanoparticles: does it really matter?","volume":"5","author":"Tak","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2020.02.005_bb0410","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1021\/nn403913k","article-title":"Synergistic targeting of cell membrane, cytoplasm, and nucleus of cancer cells using rod-shaped nanoparticles","volume":"7","author":"Barua","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.02.005_bb0415","first-page":"1","article-title":"The advances of carbon nanotubes in cancer diagnostics and therapeutics","volume":"2017","author":"Chen","year":"2017","journal-title":"J. Nanomater."},{"key":"10.1016\/j.addr.2020.02.005_bb0420","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2020.02.005_bb0425","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nnano.2016.269","article-title":"Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo","volume":"12","author":"Chen","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2020.02.005_bb0430","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1517\/17425247.2011.574610","article-title":"Charged liposomes as carriers to enhance the permeation through the skin","volume":"8","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2020.02.005_bb0435","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.2174\/1381612824666180807120017","article-title":"Current non-viral siRNA delivery systems as a promissing treatment of skin diseases","volume":"24","author":"Rosa","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2020.02.005_bb0440","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.addr.2017.12.011","article-title":"miRNA delivery for skin wound healing","volume":"129","author":"Meng","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0445","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1007\/s12274-018-2124-7","article-title":"Polymer nanoparticles as adjuvants in cancer immunotherapy","volume":"11","author":"Li","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.addr.2020.02.005_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.02.040","article-title":"Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: challenges and opportunities","volume":"277","author":"Belfiore","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0455","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.colsurfb.2017.07.085","article-title":"Immunoliposomes: a review on functionalization strategies and targets for drug delivery","volume":"159","author":"Eloy","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb0460","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ab.2018.03.008","article-title":"The potential of aptamers for cancer research","volume":"549","author":"Zhou","year":"2018","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.addr.2020.02.005_bb0465","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1166\/jbn.2016.2211","article-title":"Liquid crystalline nanodispersions functionalized with cell-penetrating peptides for topical delivery of short-interfering RNAs: a proposal for silencing a pro-inflammatory cytokine in cutaneous diseases","volume":"12","author":"Petrilli","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.addr.2020.02.005_bb0470","first-page":"1643","article-title":"Matrix metalloproteinases-2\/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation","volume":"11","author":"Zhang","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2020.02.005_bb0475","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.addr.2017.12.011","article-title":"miRNA delivery for skin wound healing","volume":"129","author":"Meng","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0480","doi-asserted-by":"crossref","first-page":"1801847","DOI":"10.1002\/advs.201801847","article-title":"Emerging nano-\/microapproaches for cancer immunotherapy","volume":"6","author":"Mi","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0485","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biomaterials.2018.04.003","article-title":"Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles","volume":"170","author":"Bocanegra Gondan","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb0490","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2016.02.035","article-title":"Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2K b and H-2D b -restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma","volume":"228","author":"Zhuang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0495","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biomaterials.2017.09.029","article-title":"Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response","volume":"149","author":"Liang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb0500","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biomaterials.2016.07.005","article-title":"Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy","volume":"104","author":"Hassan","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb0505","series-title":"Emerg. Nanotechnologies Diagnostics, Drug Deliv. Med. Devices","first-page":"169","article-title":"Nanotechnology in intracellular trafficking, imaging, and delivery of therapeutic agents","author":"Ray","year":"2017"},{"key":"10.1016\/j.addr.2020.02.005_bb0510","doi-asserted-by":"crossref","first-page":"12134","DOI":"10.1021\/acsnano.7b05214","article-title":"Light-responsive nanoparticles for highly efficient cytoplasmic delivery of anticancer agents","volume":"11","author":"Wang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.02.005_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24061035","article-title":"Polymeric co-delivery systems in cancer treatment: an overview on component drugs\u2019 dosage ratio effect","volume":"24","author":"Pan","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2020.02.005_bb0520","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2020.02.005_bb0525","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/17435390.2017.1292371","article-title":"Biocompatibility and characterization of polyglycerol-based thermoresponsive nanogels designed as novel drug-delivery systems and their intracellular localization in keratinocytes","volume":"11","author":"Gerecke","year":"2017","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.addr.2020.02.005_bb0530","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/ars.2012.4831","article-title":"Downregulation of tumor growth and invasion by redox-Active nanoparticles","volume":"19","author":"Alili","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.addr.2020.02.005_bb0535","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/jps.24291","article-title":"Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol)","volume":"104","author":"Fu","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0540","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cis.2013.11.018","article-title":"Niosomes from 80s to present: the state of the art","volume":"205","author":"Marianecci","year":"2014","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0545","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.colsurfb.2014.12.041","article-title":"Nanotechnological carriers for cancer chemotherapy: the state of the art","volume":"126","author":"Estanqueiro","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb0550","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jconrel.2013.05.020","article-title":"Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches","volume":"170","author":"Pradhan","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01057","article-title":"Pharmacokinetic aspects of nanoparticle-in-matrix drug delivery systems for oral\/buccal delivery","volume":"10","author":"Feitosa","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2020.02.005_bb0560","doi-asserted-by":"crossref","first-page":"16517","DOI":"10.1038\/s41598-017-16878-1","article-title":"Dacarbazine nanoparticle topical delivery system for the treatment of melanoma","volume":"7","author":"Hafeez","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2020.02.005_bb0565","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2147\/IJN.S105016","article-title":"Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials","volume":"11","author":"Abdulbaqi","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2020.02.005_bb0570","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/1061186X.2015.1070855","article-title":"Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment","volume":"24","author":"Garg","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2020.02.005_bb0575","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2016.09.007","article-title":"Improved topical delivery of tacrolimus: a novel composite hydrogel formulation for the treatment of psoriasis","volume":"242","author":"Gabriel","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0580","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.apsb.2015.09.006","article-title":"Pharmacokinetic and pharmacodynamic study of triptolide-loaded liposome hydrogel patch under microneedles on rats with collagen-induced arthritis","volume":"5","author":"Chen","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2020.02.005_bb0585","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2017.03.385","article-title":"Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel","volume":"254","author":"Sun","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0590","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/187221312802652785","article-title":"Innovative topical formulations for treatment of dermatitis","volume":"6","author":"Senyigit","year":"2012","journal-title":"Recent Patents Inflamm. Allergy Drug Discov."},{"key":"10.1016\/j.addr.2020.02.005_bb0595","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1039\/C6CS00409A","article-title":"Lipid-based nanovesicles for nanomedicine","volume":"45","author":"Grimaldi","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.10.046","article-title":"Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications","volume":"535","author":"Sala","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bb0605","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2019.02.012","article-title":"Lipid gene nanocarriers for the treatment of skin diseases: current state-of-the-art","volume":"137","author":"Bellefroid","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2020.02.005_bb0610","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.addr.2020.02.005_bb0615","doi-asserted-by":"crossref","first-page":"e92978","DOI":"10.1371\/journal.pone.0092978","article-title":"Microfluidic-enabled liposomes elucidate size-dependent transdermal transport","volume":"9","author":"Hood","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2020.02.005_bb0620","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.colsurfb.2018.12.031","article-title":"PEG-coated vesicles from Pluronic\/lipid mixtures for the carrying of photoactive erythrosine derivatives","volume":"175","author":"de Freitas","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb0625","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2003.10.006","article-title":"Deformable liposomes for dermal administration of methotrexate","volume":"270","author":"Trotta","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bb0630","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","article-title":"Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties","volume":"65","author":"Touitou","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0635","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cocis.2011.06.007","article-title":"Structural properties of solid lipid based colloidal drug delivery systems","volume":"16","author":"Bunjes","year":"2011","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0640","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3109\/10717544.2016.1165310","article-title":"Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma","volume":"23","author":"Qidwai","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2020.02.005_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1573413713666170529115831","article-title":"Liquid-crystalline nanodispersions containing monoolein for photodynamic therapy of skin diseases: a mini-review","volume":"13","author":"Praca","year":"2017","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.addr.2020.02.005_bb0650","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2015.12.003","article-title":"Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: nanodispersions of liquid-crystalline phase as nanocarriers","volume":"83","author":"Rossetti","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0655","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2016.10.023","article-title":"Hybrid protein-inorganic nanoparticles: from tumor-targeted drug delivery to cancer imaging","volume":"243","author":"Elzoghby","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0660","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","article-title":"Polymer\u2013drug conjugate therapeutics: advances, insights and prospects","volume":"18","author":"Ekladious","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2020.02.005_bb0665","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2012.04.036","article-title":"Protein-based nanocarriers as promising drug and gene delivery systems","volume":"161","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0670","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2015.04.032","article-title":"Recent progress in biomedical applications of Pluronic (PF127): pharmaceutical perspectives","volume":"209","author":"Akash","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0675","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/sj.bjc.6602204","article-title":"Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin","volume":"91","author":"Matsumura","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2020.02.005_bb0680","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2014.06.042","article-title":"Progress of drug-loaded polymeric micelles into clinical studies","volume":"190","author":"Cabral","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb0685","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.progpolymsci.2007.09.003","article-title":"Polymeric nanomedicine for cancer therapy","volume":"33","author":"Park","year":"2008","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0690","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1158\/1078-0432.CCR-03-0655","article-title":"Phase I and pharmacokinetic study of Genexol-PM, a Cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advyanced malignancies","volume":"10","author":"Kim","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2020.02.005_bb0695","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.addr.2007.03.012","article-title":"Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications","volume":"59","author":"Malafaya","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0700","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejpb.2019.02.010","article-title":"Octa-arginine boosts the penetration of elastin-like polypeptide nanoparticles in 3D cancer models","volume":"137","author":"van Oppen","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2020.02.005_bb0705","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/acs.biomac.7b00064","article-title":"Self-assembling VHH-elastin-like peptides for photodynamic nanomedicine","volume":"18","author":"Pille","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2020.02.005_bb0710","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s003960050246","article-title":"Formation of gliadin nanoparticles: influence of the solubility parameter of the protein solvent","volume":"276","author":"Duclairoir","year":"1998","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0715","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1039\/c2sm06999g","article-title":"Beyond the lipid-bilayer: interaction of polymers and nanoparticles with membranes","volume":"8","author":"Schulz","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.addr.2020.02.005_bb0720","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.colsurfb.2018.10.063","article-title":"Influence of hybrid polymeric nanoparticle\/thermosensitive hydrogels systems on formulation tracking and in vitro artificial membrane permeation: a promising system for skin drug-delivery","volume":"174","author":"Grillo","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb0725","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acs.molpharmaceut.7b00894","article-title":"Solid-in-oil peptide nanocarriers for transcutaneous cancer vaccine delivery against melanoma","volume":"15","author":"Wakabayashi","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bb0730","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1021\/cr500131f","article-title":"Biodegradable polymer nanogels for drug\/nucleic acid delivery","volume":"115","author":"Li","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0735","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cplett.2010.01.027","article-title":"Effect of surface coating on the toxicity of silver nanomaterials on human skin keratinocytes","volume":"487","author":"Lu","year":"2010","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.addr.2020.02.005_bb0740","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.colsurfb.2018.10.051","article-title":"Recent advances in magnetic fluid hyperthermia for cancer therapy","volume":"174","author":"Das","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb0745","doi-asserted-by":"crossref","first-page":"10410","DOI":"10.1021\/acs.chemrev.5b00193","article-title":"Gold nanomaterials at work in biomedicine","volume":"115","author":"Yang","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0750","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1002\/adma.201602080","article-title":"Structural-engineering rationales of gold nanoparticles for cancer theranostics","volume":"28","author":"Chen","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2020.02.005_bb0755","first-page":"2544","article-title":"Low power single laser activated synergistic cancer phototherapy using photosensitizer functionalized dual plasmonic photothermal nanoagents","volume":"13","author":"Younis","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.02.005_bb0760","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1021\/acs.chemrev.6b00558","article-title":"Recent advances in ultrathin two-dimensional nanomaterials","volume":"117","author":"Tan","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0765","doi-asserted-by":"crossref","first-page":"15162","DOI":"10.1021\/acs.jpcc.6b03733","article-title":"Multifunctional Fe2O3-Au nanoparticles with different shapes: enhanced catalysis, photothermal effects, and magnetic recyclability","volume":"120","author":"Larsen","year":"2016","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.addr.2020.02.005_bb0770","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1002\/adfm.201600676","article-title":"Modulation of hypoxia in solid tumor microenvironment with MnO2 nanoparticles to enhance photodynamic therapy","volume":"26","author":"Zhu","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2020.02.005_bb0775","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1002\/adma.201505869","article-title":"Light-activated hypoxia-responsive nanocarriers for enhanced anticancer therapy","volume":"28","author":"Qian","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2020.02.005_bb0780","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41570-019-0088-0","article-title":"Polymer encapsulation of ruthenium complexes for biological and medicinal applications","volume":"3","author":"Villemin","year":"2019","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.addr.2020.02.005_bb0785","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1039\/c3cc00177f","article-title":"The path for metal complexes to a DNA target","volume":"49","author":"Komor","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2020.02.005_bb0790","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/lsm.20968","article-title":"Single-wall carbon nanotubes assisted photothermal cancer therapy: animal study with a murine model of squamous cell carcinoma","volume":"42","author":"Huang","year":"2010","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb0795","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/smll.201100669","article-title":"Mitochondria-targeting single-walled carbon nanotubes for cancer photothermal therapy","volume":"7","author":"Zhou","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.addr.2020.02.005_bb0800","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.cbpa.2005.10.005","article-title":"Applications of carbon nanotubes in drug delivery","volume":"9","author":"Bianco","year":"2005","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.addr.2020.02.005_bb0805","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1021\/acs.nanolett.6b00982","article-title":"Metal\u2013Semiconductor nanoparticle hybrids formed by self-organization: a platform to address exciton\u2013plasmon coupling","volume":"16","author":"Strelow","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2020.02.005_bb0810","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1002\/anie.201601740","article-title":"Plasmonic nanorattles as next-generation catalysts for surface plasmon resonance-mediated oxidations promoted by activated oxygen","volume":"55","author":"da Silva","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2020.02.005_bb0815","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/cr300213b","article-title":"Nanomaterials for theranostics: recent advances and future challenges","volume":"115","author":"Lim","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0820","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.biopha.2019.01.037","article-title":"Synthesis, characterization and application of plasmonic hollow gold nanoshells in a photothermal therapy\u2014new particles for theranostics","volume":"111","author":"Grabowska-Jadach","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2020.02.005_bb0825","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2016.12.026","article-title":"Multifunctional near-infrared dye-magnetic nanoparticles for bioimaging and cancer therapy","volume":"390","author":"Hou","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2020.02.005_bb0830","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbrc.2018.05.155","article-title":"A preliminary study of photoacoustic\/ultrasound dual-mode imaging in melanoma using MAGE-targeted gold nanoparticles","volume":"502","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2020.02.005_bb0835","doi-asserted-by":"crossref","first-page":"10453","DOI":"10.1021\/acsami.6b16408","article-title":"Thermally triggered in situ assembly of gold nanoparticles for cancer multimodal imaging and photothermal therapy","volume":"9","author":"Sun","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb0840","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/17425247.2015.988136","article-title":"Decationized polyplexes for gene delivery","volume":"12","author":"Novo","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2020.02.005_bb0845","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1039\/C4NR06556E","article-title":"Histidine-rich stabilized polyplexes for cMet-directed tumor-targeted gene transfer","volume":"7","author":"Kos","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2020.02.005_bb0850","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1021\/cr5006793","article-title":"Nucleic acid therapeutics using polyplexes: a journey of 50 years (and Beyond)","volume":"115","author":"L\u00e4chelt","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0855","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2009.11.006","article-title":"Non-viral gene delivery carrier and its three-dimensional transfection system","volume":"386","author":"He","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bb0860","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2796.2009.02189.x","article-title":"Lipid-based nanotherapeutics for siRNA delivery","volume":"267","author":"Schroeder","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb0865","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijbiomac.2017.12.076","article-title":"Collapse of DNA in packaging and cellular transport","volume":"109","author":"Thomas","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2020.02.005_bb0870","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2017.07.021","article-title":"Nonviral cancer gene therapy: delivery cascade and vector nanoproperty integration","volume":"115","author":"Zhou","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0875","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1038\/mtna.2016.6","article-title":"DNA as tunable adaptor for siRNA polyplex stabilization and functionalization","volume":"5","author":"Heissig","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2020.02.005_bb0880","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.nano.2014.11.006","article-title":"Recent advances in targeted nanoparticles drug delivery to melanoma","volume":"11","author":"Li","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb0885","first-page":"3","article-title":"Drug resistance in melanoma\u202f: mechanisms, apoptosis, and new potential therapeutic targets edited by Foxit reader","author":"Foxit","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2020.02.005_bb0890","doi-asserted-by":"crossref","first-page":"841817","DOI":"10.1155\/2015\/841817","article-title":"Nanotechnology-based drug delivery systems for melanoma antitumoral therapy: a review","volume":"2015","author":"Rigon","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.addr.2020.02.005_bb0895","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejps.2015.06.013","article-title":"Topical therapies for skin cancer and actinic keratosis","volume":"77","author":"Haque","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0900","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejps.2016.01.003","article-title":"Quality by design case study 1: design of 5-fluorouracil loaded lipid nanoparticles by the W\/O\/W double emulsion \u2014 solvent evaporation method","volume":"84","author":"Amasya","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0905","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1529-8019.2005.00052.x","article-title":"Cutaneous melanoma: available therapy for metastatic disease","volume":"19","author":"Tarhini","year":"2006","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.addr.2020.02.005_bb0910","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1021\/acsami.7b05278","article-title":"Dacarbazine-loaded hollow mesoporous silica nanoparticles grafted with folic acid for enhancing antimetastatic melanoma response","volume":"9","author":"Liu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb0915","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2147\/DDDT.S127328","article-title":"Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance","volume":"11","author":"Su","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2020.02.005_bb0920","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jcis.2010.12.004","article-title":"Polyphosphazene nanoparticles for cytoplasmic release of doxorubicin with improved cytotoxicity against Dox-resistant tumor cells","volume":"355","author":"Zheng","year":"2011","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0925","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020255","article-title":"Solid lipid nanoparticles carrying temozolomide for melanoma treatment. preliminary in vitro and in vivo studies","volume":"19","author":"Clemente","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb0930","article-title":"Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics","author":"Hong","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb0935","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","article-title":"The basis of oncoimmunology","volume":"164","author":"Palucka","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.addr.2020.02.005_bb0940","doi-asserted-by":"crossref","first-page":"1606036","DOI":"10.1002\/adma.201606036","article-title":"Tailoring biomaterials for cancer immunotherapy: emerging trends and future outlook","volume":"29","author":"Wang","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2020.02.005_bb0945","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/2159-8290.CD-15-0563","article-title":"Adaptive immune resistance: how cancer protects from immune attack","volume":"5","author":"Ribas","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.addr.2020.02.005_bb0950","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0956462415586316","article-title":"The risk of non-melanoma skin cancer in HIV-infected patients: new data and meta-analysis","volume":"27","author":"Zhao","year":"2016","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.addr.2020.02.005_bb0955","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.1524-4725.2012.02520.x","article-title":"Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management","volume":"38","author":"Tessari","year":"2012","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2020.02.005_bb0960","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/jid.2012.388","article-title":"Systemic immune suppression predicts diminished merkel cell carcinoma\u2013specific survival independent of stage","volume":"133","author":"Paulson","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2020.02.005_bb0965","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2020.02.005_bb0970","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/cancers8120106","article-title":"Advances in cancer immunotherapy in solid tumors","volume":"8","author":"Menon","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.addr.2020.02.005_bb0975","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.359.6382.1346","article-title":"Too much of a good thing?","volume":"359","author":"Kaiser","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2020.02.005_bb0980","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4","volume":"270","author":"Waterhouse","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.addr.2020.02.005_bb0985","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2020.02.005_bb0990","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/d41586-018-06751-0","article-title":"Cancer immunologists scoop medicine nobel prize","volume":"562","author":"Ledford","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.005_bb0995","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s12276-018-0130-1","article-title":"Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance","volume":"50","author":"Park","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb1000","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7555\/JBR.31.20160168","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"32","author":"Webb","year":"2018","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.addr.2020.02.005_bb1005","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2020.02.005_bb1010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb1015","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb1020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2020.02.005_bb1025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory pathways in immunotherapy for cancer","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2020.02.005_bb1030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"80","key":"10.1016\/j.addr.2020.02.005_bb1035","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2020.02.005_bb1040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/annonc\/mdz255.007","article-title":"Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti\u2013PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)","volume":"30","author":"Rischin","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2020.02.005_bb1045","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1172\/JCI80011","article-title":"Anti\u2013PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Chen","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2020.02.005_bb1050","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab","volume":"32","author":"Topalian","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2020.02.005_bb1055","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1001\/jamaoncol.2016.1051","article-title":"Treatment of the immune-related adverse effects of immune checkpoint inhibitors","volume":"2","author":"Friedman","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.addr.2020.02.005_bb1060","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/21645515.2016.1244149","article-title":"Is there a role for therapeutic cancer vaccines in the age of checkpoint inhibitors?","volume":"13","author":"Dillman","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"issue":"80","key":"10.1016\/j.addr.2020.02.005_bb1065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.addr.2020.02.005_bb1070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/med.21404","article-title":"Metastatic melanoma: insights into the evolution of the treatments and future challenges","volume":"37","author":"Millet","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb1075","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1634\/theoncologist.2012-0123","article-title":"U.S. Food and drug administration approval: peginterferon-alfa-2b for the adjuvant treatment of patients with melanoma","volume":"17","author":"Herndon","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.addr.2020.02.005_bb1080","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/1097-0142(19950815)76:4<687::AID-CNCR2820760424>3.0.CO;2-M","article-title":"The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma","volume":"76","author":"Yang","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.addr.2020.02.005_bb1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2019.01.015","article-title":"Unleash the power of the mighty T cells-basis of adoptive cellular therapy","volume":"136","author":"Sukari","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.addr.2020.02.005_bb1090","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00262-019-02307-x","article-title":"Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2","volume":"68","author":"Nguyen","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.addr.2020.02.005_bb1095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature18945","article-title":"Neoantigen landscape dynamics during human melanoma\u2013T cell interactions","volume":"536","author":"Verdegaal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.005_bb1100","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2020.02.005_bb1105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2009-03-211714","article-title":"Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.addr.2020.02.005_bb1110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3643","article-title":"Adoptive cellular therapy: a race to the finish line","volume":"7","author":"June","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb1115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-019-0103-y","article-title":"Turning the corner on therapeutic cancer vaccines","volume":"4","author":"Hollingsworth","year":"2019","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.addr.2020.02.005_bb1120","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.4161\/21645515.2014.980686","article-title":"DNA vaccine for cancer immunotherapy","volume":"10","author":"Yang","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.addr.2020.02.005_bb1125","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: moving beyond current vaccines","volume":"10","author":"Rosenberg","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb1130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.005_bb1135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.005_bb1140","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2020.02.005_bb1145","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1056\/NEJMoa1012863","article-title":"gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma","volume":"364","author":"Schwartzentruber","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb1150","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.addr.2020.02.005_bb1155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/14760584.2016.1145057","article-title":"Cancer vaccines: limited success but the research should remain viable","volume":"15","author":"Baxevanis","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.addr.2020.02.005_bb1160","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.molonc.2014.07.011","article-title":"Acquired and intrinsic resistance in cancer immunotherapy","volume":"8","author":"Kelderman","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.addr.2020.02.005_bb1165","author":"Rowena"},{"key":"10.1016\/j.addr.2020.02.005_bb1170","article-title":"Nanoparticle-based nanomedicines to promote cancer immunotherapy: recent advances and future directions","volume":"1900262","author":"Liu","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.addr.2020.02.005_bb1175","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","article-title":"Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors","volume":"12","author":"Dai","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.02.005_bb1180","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biomaterials.2018.05.025","article-title":"Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy","volume":"175","author":"Lu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb1185","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1039\/C7TB00819H","article-title":"MgAl-layered double hydroxide nanoparticles co-delivering siIDO and Trp2 peptide effectively reduce IDO expression and induce cytotoxic T-lymphocyte responses against melanoma tumor in mice","volume":"5","author":"Zhang","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2020.02.005_bb1190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biomaterials.2018.05.015","article-title":"Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy","volume":"174","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb1195","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm.2198","article-title":"Therapeutic cell engineering with surface-conjugated synthetic nanoparticles","volume":"16","author":"Stephan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb1200","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41467-017-01830-8","article-title":"T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity","volume":"8","author":"Schmid","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2020.02.005_bb1205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2016.01.044","article-title":"Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation","volume":"231","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb1210","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1021\/acs.nanolett.5b05030","article-title":"Enhanced cancer immunotherapy by microneedle patch-assisted delivery of Anti-PD1 antibody","volume":"16","author":"Wang","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2020.02.005_bb1215","doi-asserted-by":"crossref","first-page":"8956","DOI":"10.1021\/acsnano.6b04989","article-title":"Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors","volume":"10","author":"Ye","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.02.005_bb1220","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nmat3355","article-title":"Combination delivery of TGF-\u03b2 inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy","volume":"11","author":"Park","year":"2012","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2020.02.005_bb1225","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/0008-5472.CAN-12-3343","article-title":"Localized immunotherapy via liposome-anchored Anti-CD137 + IL-2 prevents lethal toxicity and elicits local and systemic antitumor immunity","volume":"73","author":"Kwong","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2020.02.005_bb1230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cell.2015.03.037","article-title":"Immunoengineering: how nanotechnology can enhance cancer immunotherapy","volume":"161","author":"Goldberg","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.addr.2020.02.005_bb1235","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/nn405520d","article-title":"Magnetic field-induced t cell receptor clustering by nanoparticles enhances t cell activation and stimulates antitumor activity","volume":"8","author":"Perica","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.02.005_bb1240","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.4161\/21645515.2014.980686","article-title":"DNA vaccine for cancer immunotherapy","volume":"10","author":"Yang","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.addr.2020.02.005_bb1245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2020.02.005_bb1250","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.005_bb1255","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2020.02.005_bb1260","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1002\/adfm.201501283","article-title":"Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumor-associated macrophages and cancer cells","volume":"25","author":"Conde","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2020.02.005_bb1265","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/s41467-017-01386-7","article-title":"Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2020.02.005_bb1270","doi-asserted-by":"crossref","first-page":"9536","DOI":"10.1021\/acsnano.7b05465","article-title":"Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages","volume":"11","author":"Qian","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.02.005_bb1275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.01.013","article-title":"An indoleamine 2, 3-dioxygenase siRNA nanoparticle-coated and Trp2-displayed recombinant yeast vaccine inhibits melanoma tumor growth in mice","volume":"273","author":"Liu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb1280","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biomaterials.2018.05.015","article-title":"Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy","volume":"174","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb1285","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nmat4822","article-title":"Designer vaccine nanodiscs for personalized cancer immunotherapy","volume":"16","author":"Kuai","year":"2017","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2020.02.005_bb1290","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41563-018-0028-2","article-title":"A facile approach to enhance antigen response for personalized cancer vaccination","volume":"17","author":"Li","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2020.02.005_bb1295","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2017.52","article-title":"A STING-activating nanovaccine for cancer immunotherapy","volume":"12","author":"Luo","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2020.02.005_bb1300","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2019.02.012","article-title":"Lipid gene nanocarriers for the treatment of skin diseases: current state-of-the-art","volume":"137","author":"Bellefroid","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2020.02.005_bb1305","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng1092-93","article-title":"A brief history of gene therapy","volume":"2","author":"Friedmann","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.addr.2020.02.005_bb1310","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gene.2013.03.137","article-title":"History of gene therapy","volume":"525","author":"Wirth","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.addr.2020.02.005_bb1315","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcp.24791","article-title":"Gene therapies for cancer: strategies, challenges and successes","volume":"230","author":"Das","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.addr.2020.02.005_bb1320","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1006\/mthe.2002.0601","article-title":"IL-12 plasmid delivery by in Vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma","volume":"5","author":"Lucas","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2020.02.005_bb1325","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1200\/JCO.2007.15.6794","article-title":"Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma","volume":"26","author":"Daud","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2020.02.005_bb1330","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.005_bb1335","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1046-2023(02)00023-3","article-title":"Analysis of gene function in somatic mammalian cells using small interfering RNAs","volume":"26","author":"Elbashir","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.addr.2020.02.005_bb1340","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2202-3-18","article-title":"Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake","volume":"3","author":"Makimura","year":"2002","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.addr.2020.02.005_bb1345","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.gt.3302653","article-title":"Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders","volume":"13","author":"Campochiaro","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2020.02.005_bb1350","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1261\/rna.459807","article-title":"Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting","volume":"13","author":"de Paula","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.addr.2020.02.005_bb1355","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mam.2006.12.004","article-title":"RNA interference: implications for cancer treatment","volume":"28","author":"Masiero","year":"2007","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb1360","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2020.02.005_bb1365","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.addr.2012.08.014","article-title":"RNAi-based nanomedicines for targeted personalized therapy","volume":"64","author":"Daka","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb1370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature04263","article-title":"An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection","volume":"439","author":"Palliser","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.addr.2020.02.005_bb1375","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mrrev.2011.09.001","article-title":"Post-transcriptional gene silencing by RNA interference in non-mammalian vertebrate systems: where do we stand?","volume":"728","author":"Sifuentes-Romero","year":"2011","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"10.1016\/j.addr.2020.02.005_bb1380","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/oli.1.1999.9.451","article-title":"Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide","volume":"5","author":"Putney","year":"1999","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.addr.2020.02.005_bb1385","first-page":"1002","article-title":"Gene therapy for treatment of melanoma cancer","volume":"1","author":"Chakrabort","year":"2017","journal-title":"Ann. Appl. Microbiol. Biotechnol. J."},{"key":"10.1016\/j.addr.2020.02.005_bb1390","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2796.2009.02189.x","article-title":"Lipid-based nanotherapeutics for siRNA delivery","volume":"267","author":"Schroeder","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb1395","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.biomaterials.2013.12.079","article-title":"Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma","volume":"35","author":"Siu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb1400","series-title":"Topical Delivery of siRNA-Based Spherical Nucleic Acid Nanoparticle Conjugates for Gene Regulation","first-page":"11975","volume":"109","author":"Zheng","year":"2012"},{"key":"10.1016\/j.addr.2020.02.005_bb1405","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.1021\/acsami.6b16378","article-title":"Transdermal gene delivery by functional peptide-conjugated cationic gold nanoparticle reverses the progression and metastasis of cutaneous melanoma","volume":"9","author":"Niu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb1410","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jconrel.2009.06.017","article-title":"Anionic amino acid-derived cationic lipid for siRNA delivery","volume":"140","author":"Suh","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb1415","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.biomaterials.2009.11.003","article-title":"The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine","volume":"31","author":"Alshamsan","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb1420","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejps.2015.04.017","article-title":"An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs","volume":"74","author":"Borgheti-Cardoso","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb1425","series-title":"Targeting V600E B-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development","first-page":"7638","author":"Tran","year":"2008"},{"key":"10.1016\/j.addr.2020.02.005_bb1430","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.colsurfb.2016.05.076","article-title":"Transcutaneous iontophoretic delivery of STAT3 siRNA using layer-by-layer chitosan coated gold nanoparticles to treat melanoma","volume":"146","author":"Labala","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb1435","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00002371-199903000-00005","article-title":"Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy","volume":"2","author":"Rakhmilevich","year":"1999","journal-title":"J. Immunother."},{"key":"10.1016\/j.addr.2020.02.005_bb1440","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.biopha.2016.09.098","article-title":"Percutaneous penetration of anticancer agents: past, present and future","volume":"84","author":"Ita","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2020.02.005_bb1445","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2018.02.003","article-title":"Combined use of nanocarriers and physical methods for percutaneous penetration enhancement","volume":"127","author":"Dragicevic","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb1450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers9020019","article-title":"Oncologic photodynamic therapy: basic principles, current clinical status and future directions","volume":"9","author":"van Straten","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.addr.2020.02.005_bb1455","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2018.10.042","article-title":"Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma","volume":"80","author":"Keyal","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.02.005_bb1460","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2003.09.002","article-title":"Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters","volume":"56","author":"Vianna Lopez","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb1465","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijpharm.2017.01.004","article-title":"Application of aluminum chloride phthalocyanine-loaded solid lipid nanoparticles for photodynamic inactivation of melanoma cells","volume":"518","author":"Goto","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bb1470","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijpharm.2018.06.057","article-title":"Dermal delivery of Fe-chlorophyllin via ultradeformable nanovesicles for photodynamic therapy in melanoma animal model","volume":"548","author":"Rady","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bb1475","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pdpdt.2018.05.017","article-title":"Targeted photodynamic-induced singlet oxygen production by peptide-conjugated biodegradable nanoparticles for treatment of skin melanoma","volume":"23","author":"Sebak","year":"2018","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.addr.2020.02.005_bb1480","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jcis.2018.03.063","article-title":"Polymer-free cubosomes for simultaneous bioimaging and photodynamic action of photosensitizers in melanoma skin cancer cells","volume":"522","author":"Bazyli\u0144ska","year":"2018","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb1485","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/jps.22522","article-title":"Analysis of liquid crystalline nanoparticles by small angle X-ray diffraction: evaluation of drug and pharmaceutical additives influence on the internal structure","volume":"100","author":"Rossetti","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb1490","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/DSS.0000000000001048","article-title":"An analysis of laser therapy for the treatment of nonmelanoma skin cancer","volume":"43","author":"Soleymani","year":"2017","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.addr.2020.02.005_bb1495","doi-asserted-by":"crossref","first-page":"22657","DOI":"10.1039\/C8NR07627H","article-title":"Recent advances in nanomaterials for enhanced photothermal therapy of tumors","volume":"10","author":"Hu","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2020.02.005_bb1500","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s10103-018-2538-1","article-title":"Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: an in vitro and animal model investigation","volume":"33","author":"Rahimi-Moghaddam","year":"2018","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb1505","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijbiomac.2017.11.163","article-title":"NIR triggered liposome gold nanoparticles entrapping curcumin as in situ adjuvant for photothermal treatment of skin cancer","volume":"110","author":"Singh","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2020.02.005_bb1510","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.2147\/IJN.S156240","article-title":"Cantharidin-encapsulated thermal-sensitive liposomes coated with gold nanoparticles for enhanced photothermal therapy on A431 cells","volume":"13","author":"Wang","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2020.02.005_bb1515","doi-asserted-by":"crossref","first-page":"21640","DOI":"10.1039\/C8NR05323E","article-title":"BSA-bioinspired gold nanorods loaded with immunoadjuvant for the treatment of melanoma by combined photothermal therapy and immunotherapy","volume":"10","author":"Zhou","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2020.02.005_bb1520","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1021\/jacs.7b11036","article-title":"Synthesis of hollow biomineralized CaCO 3 \u2013polydopamine nanoparticles for multimodal imaging-guided cancer photodynamic therapy with reduced skin photosensitivity","volume":"140","author":"Dong","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2020.02.005_bb1525","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1039\/C8CS00618K","article-title":"Photothermal therapy and photoacoustic imaging: via nanotheranostics in fighting cancer","volume":"48","author":"Liu","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb1530","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10585-018-9923-9","article-title":"Frontiers of cancer imaging and guided therapy using ultrasound, light, and microwaves","volume":"35","author":"Witte","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.addr.2020.02.005_bb1535","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/smll.201502857","article-title":"Chemo\/photoacoustic dual therapy with mRNA-triggered DOX release and photoinduced shockwave based on a DNA-gold nanoplatform","volume":"12","author":"Zang","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.addr.2020.02.005_bb1540","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1039\/C8NR08498J","article-title":"Explosible nanocapsules excited by pulsed microwaves for efficient thermoacoustic-chemo combination therapy","volume":"11","author":"Wang","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2020.02.005_bb1545","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2018.06.020","article-title":"Use of iontophoresis for the treatment of cancer","volume":"284","author":"Byrne","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb1550","series-title":"Co-delivery of Curcumin and STAT3 siRNA Using Deformable Cationic Liposomes to Treat Skin Cancer","author":"Jose","year":"2017"},{"key":"10.1016\/j.addr.2020.02.005_bb1555","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1021\/mp5007163","article-title":"Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma","volume":"12","author":"Labala","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bb1560","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijpharm.2017.03.087","article-title":"Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles","volume":"525","author":"Labala","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bb1565","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1208\/s12249-017-0833-y","article-title":"Effective skin cancer treatment by topical co-delivery of curcumin and STAT3 siRNA using cationic liposomes","volume":"19","author":"Jose","year":"2017","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.addr.2020.02.005_bb1570","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2018.05.038","article-title":"Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection","volume":"283","author":"Petrilli","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb1575","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1039\/C4NR05241B","article-title":"Topical gene silencing by iontophoretic delivery of an antisense oligonucleotide-dendrimer nanocomplex: the proof of concept in a skin cancer mouse model","volume":"7","author":"Venuganti","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2020.02.005_bb1580","first-page":"1","article-title":"The use of electrochemotherapy in combination with immunotherapy in the treatment of metastatic melanoma: a focused review","author":"Goggins","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.addr.2020.02.005_bb1585","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/1061186X.2018.1464012","article-title":"Recent advances in ultrasound-triggered therapy","volume":"27","author":"Yang","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2020.02.005_bb1590","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2018.10.007","article-title":"Crosslinked self-assembled nanoparticles for chemo-sonodynamic combination therapy favoring antitumor, antimetastasis management and immune responses","volume":"290","author":"Liu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb1595","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.119.256487","article-title":"Ultrasound triggered spatiotemporal delivery of topotecan and curcumin as combination therapy for cancer","author":"Prasad","year":"2019","journal-title":"J. Pharmacol. Exp.Ther."},{"key":"10.1016\/j.addr.2020.02.005_bb1600","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","article-title":"Microneedles: a smart approach and increasing potential for transdermal drug delivery system","volume":"109","author":"Waghule","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2020.02.005_bb1605","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1166\/jbn.2017.2474","article-title":"Microneedles-based transdermal drug delivery systems: a review","volume":"13","author":"Hao","year":"2017","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.addr.2020.02.005_bb1610","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1021\/acsami.7b03604","article-title":"Novel approach of using near-infrared responsive PEGylated gold nanorod coated Poly(l-lactide) microneedles to enhance the antitumor efficiency of Docetaxel-loaded MPEG-PDLLA micelles for TREATING an A431 tumor","volume":"9","author":"Hao","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb1615","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.msec.2019.02.095","article-title":"Derma roller\u00ae microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect","volume":"99","author":"Ahmed","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2020.02.005_bb1620","doi-asserted-by":"crossref","first-page":"11936","DOI":"10.1021\/acsnano.8b03007","article-title":"Microneedle-assisted topical delivery of photodynamically active mesoporous formulation for combination therapy of deep-seated melanoma","volume":"12","author":"Tham","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2020.02.005_bb1625","doi-asserted-by":"crossref","first-page":"33060","DOI":"10.1021\/acsami.8b12926","article-title":"Microneedle-mediated delivery of lipid-coated cisplatin nanoparticles for efficient and safe cancer therapy","volume":"10","author":"Lan","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2020.02.005_bb1630","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.addr.2015.10.014","article-title":"Co-delivery of drugs and plasmid DNA for cancer therapy","volume":"98","author":"Teo","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb1635","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: an industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.02.005_bb1640","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2020.02.005_bb1645","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1080\/10717544.2017.1370619","article-title":"Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy","volume":"24","author":"Zhou","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2020.02.005_bb1650","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1039\/C8BM01403E","article-title":"A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model","volume":"7","author":"Banerjee","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb1655","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.nano.2017.12.017","article-title":"Redox-responsive micelles from disulfide bond-bridged hyaluronic acid-tocopherol succinate for the treatment of melanoma","volume":"14","author":"Xia","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2020.02.005_bb1660","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2017.07.023","article-title":"Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models","volume":"109","author":"Carvalho","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb1665","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-019-1316-0","article-title":"Co-delivery of doxorubicin and ceramide in a liposomal formulation enhances cytotoxicity in murine B16BL6 melanoma cell lines","volume":"20","author":"Chen","year":"2019","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.addr.2020.02.005_bb1670","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/10717544.2016.1225853","article-title":"Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency","volume":"24","author":"Wang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2020.02.005_bb1675","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.actbio.2019.03.022","article-title":"Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention","volume":"89","author":"Rao","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2020.02.005_bb1680","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/21691401.2018.1452021","article-title":"Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model","volume":"46","author":"Tavakoli","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.addr.2020.02.005_bb1685","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/pharmaceutics11040163","article-title":"Co-delivery of eugenol and dacarbazine by hyaluronic acid-coated liposomes for targeted inhibition of survivin in treatment of resistant metastatic melanoma","volume":"11","author":"Mishra","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2020.02.005_bb1690","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2016.02.035","article-title":"Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2K b and H-2D b -restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma","volume":"228","author":"Zhuang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb1695","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biomaterials.2018.05.025","article-title":"Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy","volume":"175","author":"Lu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb1700","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biomaterials.2018.05.015","article-title":"Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy","volume":"174","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2020.02.005_bb1705","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7150\/thno.29026","article-title":"Low molecular weight heparin-coated and dendrimer-based core-shell nanoplatform with enhanced immune activation and multiple anti-metastatic effects for melanoma treatment","volume":"9","author":"Xia","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2020.02.005_bb1710","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jconrel.2017.11.037","article-title":"Immunochemotherapy mediated by thermosponge nanoparticles for synergistic anti-tumor effects","volume":"269","author":"Zhao","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb1715","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1021\/acs.molpharmaceut.8b00564","article-title":"Co-delivery of doxorubicin and interferon-\u03b3 by thermosensitive nanoparticles for cancer immunochemotherapy","volume":"15","author":"Yin","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bb1720","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2017.04.011","article-title":"Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy","volume":"255","author":"Wu","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.02.005_bb1725","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2147\/IJN.S190736","article-title":"Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response","volume":"14","author":"Saeed","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2020.02.005_bb1730","first-page":"1","article-title":"Physical methods for topical skin drug delivery: concepts and applications","volume":"54","author":"Petrilli","year":"2018","journal-title":"Brazilian J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.02.005_bb1735","doi-asserted-by":"crossref","DOI":"10.1007\/s10544-018-0298-0","article-title":"Micelle-like nanoparticles as siRNA and miRNA carriers for cancer therapy","volume":"20","author":"Costa","year":"2018","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.addr.2020.02.005_bb1740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep35223","article-title":"Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma","volume":"6","author":"Reddy","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2020.02.005_bb1745","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2147\/IJN.S147759","article-title":"Co-delivery of aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy","volume":"13","author":"Duan","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2020.02.005_bb1750","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ymthe.2017.11.009","article-title":"mRNA vaccine with antigen-specific checkpoint blockade induces an enhanced immune response against established melanoma","volume":"26","author":"Wang","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2020.02.005_bb1755","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/1440-1681.12581","article-title":"Molecular mechanisms for tumour resistance to chemotherapy","volume":"43","author":"Pan","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.addr.2020.02.005_bb1760","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2020.02.005_bib1761","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bip.23029","article-title":"Inhibition of melanoma metastasis by dual-peptide PLGA NPS","volume":"108","author":"Arruda","year":"2017","journal-title":"Biopolymers"},{"key":"10.1016\/j.addr.2020.02.005_bib1762","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/anie.201708689","article-title":"Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy","volume":"57","author":"Wang","year":"2018","journal-title":"Angew Chem. Int Ed. Engl."},{"key":"10.1016\/j.addr.2020.02.005_bib1763","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.2147\/OTT.S169957","article-title":"All-trans retinoic acid-encapsulated, CD20 antibody-conjugated poly(lactic-co-glycolic acid) nanoparticles effectively target and eliminate melanoma-initiating cells in vitro","volume":"11","author":"Chen","year":"2018","journal-title":"Onco. Targets. Ther"},{"key":"10.1016\/j.addr.2020.02.005_bib1764","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.7b12233","article-title":"Improving Tumor Specificity and Anticancer Activity of Dasatinib by Dual-Targeted Polymeric Micelles","volume":"9","author":"Yao","year":"2017","journal-title":"Interfaces ACS Appl Mater."},{"key":"10.1016\/j.addr.2020.02.005_bib1765","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2016.10.029","article-title":"Redox-sensitive mPEG-SS-PTX\/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance","volume":"515","author":"Zhao","year":"2016","journal-title":"Int J Pharm."},{"key":"10.1016\/j.addr.2020.02.005_bib1766","article-title":"Enhanced Melanoma-Targeted Therapy by \u201cFru-Blocked\u201d Phenyboronic Acid-Modified Multiphase Antimetastatic Micellar Nanoparticles","volume":"5","author":"Long","year":"2018","journal-title":"Adv Sci (Weinh)."},{"key":"10.1016\/j.addr.2020.02.005_bib1767","doi-asserted-by":"crossref","DOI":"10.7150\/thno.20745","article-title":"Rational design of polymeric hybrid micelles to overcome lymphatic and intracellular delivery barriers in cancer immunotherapy","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics."},{"key":"10.1016\/j.addr.2020.02.005_bib1768","article-title":"Bioreducible Cross-Linked Hyaluronic Acid\/Calcium Phosphate Hybrid Nanoparticles for Specific Delivery of siRNA in Melanoma Tumor Therapy","volume":"9","author":"Zhou","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2020.02.005_bib1769","first-page":"261","article-title":"Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells.","volume":"39","author":"Zeng","year":"2018","journal-title":"Acta Pharmacol"},{"key":"10.1016\/j.addr.2020.02.005_bib1770","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2017.1388452","article-title":"2-Hydroxyoleic acid-inserted liposomes as a multifunctional carrier of anticancer drugs","volume":"24","author":"Jang","year":"2017","journal-title":"Drug Delivery"},{"key":"10.1016\/j.addr.2020.02.005_bib1771","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.8b03800","article-title":"Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X20300119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X20300119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:46:23Z","timestamp":1759207583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X20300119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":363,"alternative-id":["S0169409X20300119"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2020.02.005","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology approaches in the current therapy of skin cancer","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2020.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}